Gilead Sciences Inc
(NASDAQ: GILD)
+0.56
+1.00%
| Shares Outstanding | 1.53 Bil |
| Institutional Ownership (%) | 97.42 |
| Top 10 Institutions (%) | 47.50 |
| Mutual Fund Ownership (%) | 1.67 |
| 5%/Insider Ownership (%) | 0.31 |
| Float (%) | 99.69 |
| DESCRIPTION | # OF HOLDERS | SHARES |
|---|---|---|
| Total Positions | 960 | 1,485,679,111 |
| New Positions | 117 | 0 |
| Soldout Positions | 197 | 0 |
| Net Position Change | -156 | 5,096,957 |
| Buyers | 464 | 103,128,196 |
| Sellers | 620 | -98,031,239 |
| MUTUAL FUND | SHS HELD | SHS CHG | %CHG | $CHG* | %OUT | %PORT | RPT DATE |
|---|---|---|---|---|---|---|---|
| American Funds Growth Fund of America | 99,675,100 | -3,953,700 | -3.8 | 1,071,813,570 | 6.5 | 4.9 | 03-31-13 |
| American Funds Investment Company of America | 35,880,000 | 1,581,400 | 4.6 | 496,179,622 | 2.4 | 3.4 | 03-31-13 |
| AMCAP Fund | 26,272,142 | -250,000 | -0.9 | 311,600,354 | 1.7 | 5.3 | 03-31-13 |
| Vanguard Total Stock Market Index Fund | 21,100,330 | 858,800 | 4.2 | 289,178,753 | 1.4 | 0.4 | 03-31-13 |
| American Funds Capital World Growth & Income Fund | 18,860,000 | 0 | 0 | 230,280,600 | 1.2 | 1.4 | 03-31-13 |
| American Funds Insurance Series Growth-Income Fund | 15,402,000 | 0 | 0 | 54,831,120 | 1 | 2.9 | 12-31-12 |
| American Funds Fundamental Investors Fund, Inc. | 15,113,790 | 13,790 | 0.1 | 185,045,883 | 1 | 1.5 | 03-31-13 |
| PowerShares QQQ Trust - Series 1 | 14,892,800 | 92,800 | 0.6 | 29,859,392 | 1 | 2.3 | 04-30-13 |
| Vanguard 500 Index Fund | 14,473,295 | 402,123 | 2.9 | 191,488,910 | 0.9 | 0.5 | 03-31-13 |
| T. Rowe Price Growth Stock Fund | 14,369,000 | 7,191,400 | 100.2 | 439,585,612 | 0.9 | 2.1 | 03-31-13 |
| Vanguard Institutional Index Fund | 14,310,285 | 426,263 | 3.1 | 190,385,220 | 0.9 | 0.5 | 03-31-13 |
| SPDR S&P 500 ETF | 14,131,346 | -903,464 | -6 | 139,359,502 | 0.9 | 0.5 | 03-31-13 |
| American Funds American Balanced Fund | 13,128,500 | -1,071,500 | -7.5 | 120,942,790 | 0.9 | 1.6 | 03-31-13 |
| Fidelity Contrafund | 12,731,786 | -23,014 | -0.2 | 154,609,803 | 0.8 | 0.7 | 03-31-13 |
| Fidelity Select Biotechnology Portfolio | 12,472,826 | 2,313,282 | 22.8 | 237,260,053 | 0.8 | 14.8 | 03-31-13 |
- *Category Headings:
- Shs Held - shares held at report date
- Shs Chg - position change within reporting period
- %Chg - % change
- $Chg - market value of the position change
- %Out - % of shares outstanding
- %Port - % Portfolio
- Rpt Date - report date
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.